Welcome Letter

Dear Colleagues and Friends,

On behalf of the Advances in Neuroblastoma Research Association (ANRA), the ANR 2027 Organizing Committee, and the Chinese Children’s Cancer Group, it is our great pleasure to invite you to the Advances in Neuroblastoma Research Congress (ANR 2027), taking place in Shanghai, China, from May 12–15, 2027.

Building on the success of ANR 2023 in Amsterdam and ANR 2025 in Washington, D.C., ANR 2027 will bring the worldwide neuroblastoma community together once again in the historic Bund district of Shanghai. As the premier international scientific gathering dedicated to neuroblastoma, the Congress will welcome scientists, pediatric oncologists, clinicians, researchers, students, emerging investigators, and parent and patient advocates from around the world.

ANR 2027 will provide a dynamic platform to share the latest advances in our understanding of the causes and biology of neuroblastoma, as well as developments in treatment and care for children and families affected by the disease. Through scientific exchange and open discussion, we aim to explore new approaches to optimizing outcomes with current therapies, reducing treatment-related toxicities, and accelerating the development of promising novel treatments.

International collaboration remains at the heart of progress in neuroblastoma research. By bringing together diverse expertise, perspectives, and experiences from across the globe, ANR 2027 will offer an important opportunity to exchange knowledge, build new partnerships, strengthen existing collaborations, and renew our shared commitment to improving the lives of every child and family affected by neuroblastoma.

From the historic Bund to Shanghai’s cutting-edge scientific and medical community, the city provides a unique setting where East meets West, tradition meets innovation, and clinicians meet scientists.

We look forward to welcoming you to Shanghai in 2027 for four inspiring days of discovery, collaboration, and shared purpose.